A Non Interventional Long term safety Study of Ruxolitinib in Myelofibrosis (JAKAVI)

07/01/2013
18/03/2024
EU PAS number:
EUPAS3296
Study
Finalised
Documents
Study protocol
Initial protocol
English (1.75 MB - PDF) View document
Study results
Study results
English (1.52 MB - PDF) View document
Study report
Other information